908 DEVICES INC. Increase (Decrease) in Contract with Customer, Asset
908 DEVICES INC. (MASS) reported Increase (Decrease) in Contract with Customer, Asset of $63.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2021-11-04
- 908 DEVICES INC. increase (decrease) in contract with customer, asset for the quarter ending 2021-09-30 was -$44.00K.
- 908 DEVICES INC. increase (decrease) in contract with customer, asset for the quarter ending 2021-06-30 was $99.00K, a 147.50% increase year-over-year.
- 908 DEVICES INC. increase (decrease) in contract with customer, asset for the quarter ending 2021-03-31 was $8.00K, a 97.28% decline year-over-year.
- 908 DEVICES INC. increase (decrease) in contract with customer, asset for the quarter ending 2020-09-30 was -$281.00K.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month |
|---|---|---|---|
| 2021-09-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $55.00K derived: sum of 2 quarters · filed 2021-11-04 | $63.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $107.00K 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $8.00K 10-Q · filed 2021-05-13 | ||
| 2020-09-30 | -$281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$241.00K derived: sum of 2 quarters · filed 2021-11-04 | $53.00K 10-Q · filed 2021-11-04 |
| 2020-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $334.00K 10-Q · filed 2021-08-04 | |
| 2020-03-31 | $294.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |